World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
23911
World Ranking
2379
National Ranking
1138

Thomas S. Griffith publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas S. Griffith sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 260 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas S. Griffith D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas S. Griffith sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas S. Griffith is affiliated with the University of Minnesota in the United States. Their research spans several fields with a primary focus on immunology and microbiology, alongside medicine. The scientist's publication record includes 77 works in immunology and microbiology and 76 in medicine, featuring subfields such as immunology, epidemiology, molecular biology, surgery, and endocrinology, diabetes, and metabolism.

The main topics of Griffith's research encompass a range of subjects related to immune system function and disease mechanisms. These include immune response and inflammation, sepsis diagnosis and treatment, immune cell function and interaction, T-cell and B-cell immunology, immunotherapy and immune responses, neuroinflammation and neurodegeneration mechanisms, and adrenal hormones and disorders.

Griffith's frequent co-authors indicate ongoing collaborative work with other researchers. These include Vladimir P. Badovinac with 50 joint publications, Tamara A. Kucaba (22 publications), Isaac J. Jensen (17 publications), Patrick W. McGonagill (15 publications), and Whitney Swanson (12 publications).

The scientist regularly publishes in several prominent venues. The most frequent publication venues are The Journal of Immunology (20 publications), Frontiers in Immunology (5 publications), ImmunoHorizons (4 publications), bioRxiv (Cold Spring Harbor Laboratory) (4 publications), and Shock (3 publications).

Recent papers by Thomas S. Griffith reflect their focus areas and include:

  • Journal of Pharmacology and Experimental Therapeutics (2024)
  • CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State, Frontiers in Immunology (2020)
  • New Insights into the Immune System Using Dirty Mice, The Journal of Immunology (2020)
  • Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials, Immunological Investigations (2022)
  • Inducing Experimental Polymicrobial Sepsis by Cecal Ligation and Puncture, Current Protocols in Immunology (2020)

Best Publications

  • Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo

    Henning Walczak;Robert E. Miller;Kiley Ariail;Brian Gliniak

  • Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

    Thomas S. Griffith;Thomas Brunner;Sharon M. Fletcher;Douglas R. Green

  • Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells

    Thomas S. Griffith;Wilson A. Chin;Glenn C. Jackson;David H. Lynch

  • CD4 + T-cell help controls CD8 + T-cell memory via TRAIL-mediated activation-induced cell death

    Edith M. Janssen;Nathalie M. Droin;Edward E. Lemmens;Michael J. Pinkoski

  • Intravascular staining for discrimination of vascular and tissue leukocytes

    Kristin G. Anderson;Katrin Mayer-Barber;Heungsup Sung;Lalit K Beura

  • Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade

    Ziming Wang;Ethan G. Aguilar;Jesus I. Luna;Cordelia Dunai

  • TRAIL: a molecule with multiple receptors and control mechanisms

    Thomas S Griffith;David H Lynch

  • MONOCYTE-MEDIATED TUMORICIDAL ACTIVITY VIA THE TUMOR NECROSIS FACTOR-RELATED CYTOKINE, TRAIL

    Thomas S. Griffith;Steven R. Wiley;Marek Z. Kubin;Lisa M. Sedger

  • Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

    Neil A. Fanger;Charles R. Maliszewski;Ken Schooley;Thomas S. Griffith

  • CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.

    P M Stuart;T S Griffith;N Usui;J Pepose

  • CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance

    Thomas S Griffith;Xinhong Yu;John M Herndon;Douglas R Green

  • Induction of Glioblastoma Apoptosis Using Neural Stem Cell-mediated Delivery of Tumor Necrosis Factor-related Apoptosis-inducing Ligand

    Moneeb Ehtesham;Peter Kabos;Mervin A. R. Gutierrez;Nancy H. C. Chung

  • The role of FasL-induced apoptosis in immune privilege

    Thomas S. Griffith;Thomas A. Ferguson

  • Functional Analysis of TRAIL Receptors Using Monoclonal Antibodies

    Thomas S. Griffith;Charles T. Rauch;Pam J. Smolak;Jennifer Y. Waugh

  • Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis

    Yakun Gao;John M. Herndon;Hui Zhang;Thomas S. Griffith

  • Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.

    Aaron T. Ludwig;Jill M. Moore;Yi Luo;Xiaohong Chen

  • Adenoviral-Mediated Transfer of the TNF-Related Apoptosis-Inducing Ligand/Apo-2 Ligand Gene Induces Tumor Cell Apoptosis

    Thomas S. Griffith;Richard D. Anderson;Beverly L. Davidson;Richard D. Williams

  • CD8 T cells utilize TRAIL to control influenza virus infection

    Erik L. Brincks;Arna Katewa;Tamara A. Kucaba;Thomas S. Griffith

  • TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.

    Peter A. Holoch;Thomas S. Griffith

  • Uptake of Apoptotic Antigen-Coupled Cells by Lymphoid Dendritic Cells and Cross-Priming of CD8+ T Cells Produce Active Immune Unresponsiveness

    Thomas A. Ferguson;John Herndon;Bennett Elzey;Thomas S. Griffith

Frequent Co-Authors

Thomas A. Ferguson
Thomas A. Ferguson Washington University in St. Louis
Vladimir P. Badovinac
Vladimir P. Badovinac University of Iowa
Timothy L. Ratliff
Timothy L. Ratliff Purdue University West Lafayette
William M. Nauseef
William M. Nauseef University of Iowa
David M. Ferguson
David M. Ferguson University of Minnesota
Douglas R. Green
Douglas R. Green St. Jude Children's Research Hospital
Surya K. Mallapragada
Surya K. Mallapragada Iowa State University
John T. Harty
John T. Harty University of Iowa
David H. Lynch
David H. Lynch ApoVax, Inc.
Badrinath R. Konety
Badrinath R. Konety University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often overlaps with healthcare fields such as nursing and specialized practitioner roles. Many professionals opt to enhance their qualifications through online programs designed for flexibility and affordability. For those interested in mental health, exploring the cheapest online pmhnp certificate programs can be a cost-effective way to advance clinical skills in psychiatric nursing.

For nurse practitioners aiming to expand their expertise, understanding the financial implications of various specialties is crucial. The dnp salary by specialty resource offers valuable insights into earning potential, helping guide career decisions.

Transitioning between specialties is also a common pathway. For example, nurses looking to move from family practice to more acute care roles can benefit from learning how to make this shift efficiently. The guide on fnp to acute care np offers practical advice for this transition.

Additionally, accelerated programs provide a fast track to becoming a nurse practitioner. Students seeking speed and flexibility might explore the accelerated np programs online, which allow them to earn credentials without prolonged breaks in their professional journey.

By leveraging these pathways and resources, individuals interested in Immunology and related healthcare fields can find tailored programs that fit their career goals and lifestyles.

Best Scientists Citing Thomas S. Griffith

Trending Scientists

Recently Published Articles